| |
Latest 10 SEC filings (by transaction date) for PDEX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 31/24 | Jan 25/24 | Domingo Angelita Rebamontan | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 35 | $18.32 |
Aug 8/23 | Jul 27/23 | Van Kirk Richard Lee Jr | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 493 | $15.82 |
Aug 8/23 | Jul 27/23 | Domingo Angelita Rebamontan | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 41 | $15.82 |
Aug 8/23 | Jan 26/23 | Van Kirk Richard Lee Jr | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 527 | $14.79 |
Aug 8/23 | Jan 26/23 | Domingo Angelita Rebamontan | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 43 | $14.79 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for PDEX within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Jan 31/24 | Jan 25/24 | Domingo Angelita Rebamontan | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 35 | $18.32 |
Aug 8/23 | Jul 27/23 | Van Kirk Richard Lee Jr | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 493 | $15.82 |
Aug 8/23 | Jan 26/23 | Van Kirk Richard Lee Jr | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 527 | $14.79 |
Aug 8/23 | Jul 27/23 | Domingo Angelita Rebamontan | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 41 | $15.82 |
Aug 8/23 | Jan 26/23 | Domingo Angelita Rebamontan | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 43 | $14.79 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Cencora (N:COR) |
DexCom (OQ:DXCM) |
West Pharmaceutical Servi (N:WST) |